A Peek Into The Market Before The Trading Starts

Loading...
Loading...
Pre-open movers
US stock futures are higher this morning. Futures for the Dow Jones Industrial Average surged 72 points to 14,573.00 and S&P 500 index futures rose 7.10 points to 1,550.30. Nasdaq 100 futures gained 13.50 points to 2,797.00.
A Peek Into Global Markets
European markets were lower today. The STOXX Europe 600 Index fell 0.80%, London's FTSE 100 Index dropped 0.50%, French CAC 40 Index declined 0.74% and German DAX 30 index fell 0.52%. Asian markets ended mixed, with Japan's Nikkei Stock Average falling 0.41%, China's Shanghai Composite rising 0.59% and Australia's S&P/ASX 200 dropping 0.46%. Hong Kong's Hang Seng fell 0.46% and India's Sensex rose 2.03%.
Broker Recommendation
Analysts at JP Morgan downgraded C.H. Robinson Worldwide
CHRW
from “neutral” to “underweight.” The target price for C.H. Robinson has been lowered from $62 to $50. C.H. Robinson shares closed at $57.51 yesterday.
Breaking news
  • Fluor FLR announced today that it was awarded a front-end engineering and design (FEED) contract by South African Petroleum Refineries (SAPREF) for its Clean Fuels II Project in Durban, South Africa. To read the full news, click here.
  • Gentium S.p.A. GENT today announced that it has requested a re-examination of the negative opinion adopted, by the European Medicines Agency's Committee for Medicinal Products for Human Use, on March 22nd, regarding the Marketing Authorisation submitted for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell transplantation therapy. To read the full news, click here.
  • Almirall and Forest Laboratories FRX today announced positive topline results from a six month pivotal phase III clinical trial evaluating the efficacy and safety of fixed dose combinations of aclidinium bromide, (LAMA) and formoterol fumarate (LABA) delivered by Almirall's inhaler Genuair® (Pressair™ in the USA). To read the full news, click here.
  • BlackRock BLK reported a 10% gain in its first-quarter net income. To read the full news, click here.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFuturesGlobalPre-Market OutlookMarketsJP MorganUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...